These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31893550)

  • 1. Thiazolidine-2,4-dione-based irreversible allosteric IKK-β kinase inhibitors: Optimization into in vivo active anti-inflammatory agents.
    Elkamhawy A; Kim NY; Hassan AHE; Park JE; Paik S; Yang JE; Oh KS; Lee BH; Lee MY; Shin KJ; Pae AN; Lee KT; Roh EJ
    Eur J Med Chem; 2020 Feb; 188():111955. PubMed ID: 31893550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of novel thiazolidinedione derivatives as irreversible allosteric IKK-β modulators.
    Elkamhawy A; Kim NY; Hassan AHE; Park JE; Yang JE; Oh KS; Lee BH; Lee MY; Shin KJ; Lee KT; Hur W; Roh EJ
    Eur J Med Chem; 2018 Sep; 157():691-704. PubMed ID: 30130718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization study towards more potent thiazolidine-2,4-dione IKK-β modulator: Synthesis, biological evaluation and in silico docking simulation.
    Elkamhawy A; Youn Kim N; Hassan AHE; Park JE; Yang JE; Elsherbeny MH; Paik S; Oh KS; Lee BH; Lee MY; Shin KJ; Pae AN; Lee KT; Roh EJ
    Bioorg Chem; 2019 Nov; 92():103261. PubMed ID: 31542718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of thiazolidine-2,4-dione-pyrazole conjugates as antidiabetic, anti-inflammatory and antioxidant agents.
    Bansal G; Singh S; Monga V; Thanikachalam PV; Chawla P
    Bioorg Chem; 2019 Nov; 92():103271. PubMed ID: 31536952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR inhibitors from cancer to inflammation: Discovery of 4-fluoro-N-(4-(3-(trifluoromethyl)phenoxy)pyrimidin-5-yl)benzamide as a novel anti-inflammatory EGFR inhibitor.
    Elkamhawy A; Hassan AHE; Paik S; Sup Lee Y; Lee HH; Shin JS; Lee KT; Roh EJ
    Bioorg Chem; 2019 May; 86():112-118. PubMed ID: 30685642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel tight-binding inhibitory factor-kappaB kinase (IKK-2) inhibitors demonstrate target-specific anti-inflammatory activities in cellular assays and following oral and local delivery in an in vivo model of airway inflammation.
    Sommers CD; Thompson JM; Guzova JA; Bonar SL; Rader RK; Mathialagan S; Venkatraman N; Holway VW; Kahn LE; Hu G; Garner DS; Huang HC; Chiang PC; Schindler JF; Hu Y; Meyer DM; Kishore NN
    J Pharmacol Exp Ther; 2009 Aug; 330(2):377-88. PubMed ID: 19478133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, evaluation and docking of novel pyrazolo pyrimidines as potent p38α MAP kinase inhibitors with improved anti-inflammatory, ulcerogenic and TNF-α inhibitory properties.
    Somakala K; Tariq S; Amir M
    Bioorg Chem; 2019 Jun; 87():550-559. PubMed ID: 30928877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory effect of Acalypha australis L. via suppression of NF-κB signaling in LPS-stimulated RAW 264.7 macrophages and LPS-induced septic mice.
    Kim HJ; Joe HI; Zhang Z; Woo Lee S; Lee KY; Kook YB; An HJ
    Mol Immunol; 2020 Mar; 119():123-131. PubMed ID: 32014631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo therapeutics of β-thujaplicin on LPS-induced inflammation in macrophages and septic shock in mice.
    Shih MF; Chen LY; Tsai PJ; Cherng JY
    Int J Immunopathol Pharmacol; 2012; 25(1):39-48. PubMed ID: 22507316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing mosloflavone/5,6,7-trimethoxyflavone-resveratrol hybrids: Discovery of novel p38-α MAPK inhibitors as potent interceptors of macrophage-dependent production of proinflammatory mediators.
    Hassan AHE; Yoo SY; Lee KW; Yoon YM; Ryu HW; Jeong Y; Shin JS; Kang SY; Kim SY; Lee HH; Park BY; Lee KT; Lee YS
    Eur J Med Chem; 2019 Oct; 180():253-267. PubMed ID: 31310917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders.
    Farag AK; Elkamhawy A; Londhe AM; Lee KT; Pae AN; Roh EJ
    Eur J Med Chem; 2017 Dec; 141():657-675. PubMed ID: 29107425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 6-aryl-azabenzimidazoles that inhibit the TBK1/IKK-ε kinases.
    Johannes JW; Chuaqui C; Cowen S; Devereaux E; Gingipalli L; Molina A; Wang T; Whitston D; Wu X; Zhang HJ; Zinda M
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1138-43. PubMed ID: 24462666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A selective small molecule IkappaB Kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells.
    Wen D; Nong Y; Morgan JG; Gangurde P; Bielecki A; Dasilva J; Keaveney M; Cheng H; Fraser C; Schopf L; Hepperle M; Harriman G; Jaffee BD; Ocain TD; Xu Y
    J Pharmacol Exp Ther; 2006 Jun; 317(3):989-1001. PubMed ID: 16525037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
    Rim HK; Cho W; Sung SH; Lee KT
    J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity.
    Li Z; Hao Y; Yang C; Yang Q; Wu S; Ma H; Tian S; Lu H; Wang J; Yang T; He S; Zhang X
    Eur J Med Chem; 2022 Jan; 228():114036. PubMed ID: 34906762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity.
    Ziegelbauer K; Gantner F; Lukacs NW; Berlin A; Fuchikami K; Niki T; Sakai K; Inbe H; Takeshita K; Ishimori M; Komura H; Murata T; Lowinger T; Bacon KB
    Br J Pharmacol; 2005 May; 145(2):178-92. PubMed ID: 15753951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design and biological profile of (E)-N-(4-Nitrobenzylidene)-2-naphthohydrazide, a novel small molecule inhibitor of IκB kinase-β.
    Avila CM; Lopes AB; Gonçalves AS; da Silva LL; Romeiro NC; Miranda AL; Sant'Anna CM; Barreiro EJ; Fraga CA
    Eur J Med Chem; 2011 Apr; 46(4):1245-53. PubMed ID: 21334796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel paeonol derivatives: Design, synthesis and anti-inflammatory activity in vitro and in vivo.
    Hu YS; Han X; Yu PJ; Jiao MM; Liu XH; Shi JB
    Bioorg Chem; 2020 May; 98():103735. PubMed ID: 32171986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The small-molecule inhibitor selectivity between IKKα and IKKβ kinases in NF-κB signaling pathway.
    Tian F; Zhou P; Kang W; Luo L; Fan X; Yan J; Liang H
    J Recept Signal Transduct Res; 2015; 35(4):307-18. PubMed ID: 25386663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization and biological evaluation of aminopyrimidine-based IκB kinase β inhibitors with potent anti-inflammatory effects.
    Shin Y; Lim SM; Yan HH; Jung S; Fang Z; Jung KH; Hong SS; Hong S
    Eur J Med Chem; 2016 Nov; 123():544-556. PubMed ID: 27517803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.